Guangdong Brandmax Marketing
300805
Guangdong Transtek Medical Electronics
300562
Suzhou Kingswood Education Technology
300192
Broadex Technologies
300548
Hangzhou Coco Healthcare Products
301009
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 20.00%136.2M | 0.84%72.78M | -10.34%31.49M | 1.18%212.49M | 19.33%113.51M | 52.91%72.17M | 29.58%35.12M | 14.74%210.01M | 95.12M | -6.58%47.2M |
Operating revenue | 20.00%136.2M | 0.84%72.78M | -10.34%31.49M | 1.18%212.49M | 19.33%113.51M | 52.91%72.17M | 29.58%35.12M | 14.74%210.01M | --95.12M | -6.58%47.2M |
Total operating cost | 25.14%102.25M | 3.85%61.72M | -7.15%26.87M | 16.48%129.42M | 3.74%81.71M | 37.27%59.43M | 23.51%28.94M | 26.53%111.11M | 78.77M | 11.61%43.3M |
Operating cost | 21.29%32.59M | -19.95%15.43M | -10.77%6.03M | 25.04%50.37M | 35.98%26.87M | 78.93%19.28M | 18.84%6.76M | 11.62%40.28M | --19.76M | -8.64%10.77M |
Operating tax surcharges | 216.34%1.73M | 223.40%1.2M | -86.72%71.33K | -11.98%1.04M | 2.58%546.45K | 84.07%370.37K | 351.59%537.13K | -1.98%1.19M | --532.7K | -48.12%201.21K |
Operating expense | 19.42%18.91M | -1.59%11.47M | 11.40%4.97M | 82.76%28.1M | 50.98%15.83M | 80.56%11.65M | 31.65%4.46M | 110.93%15.37M | --10.48M | 150.46%6.45M |
Administration expense | -7.69%19.56M | -17.43%12.97M | -15.14%5.8M | 87.60%29.04M | 70.15%21.19M | 96.29%15.71M | 74.34%6.83M | 9.46%15.48M | --12.46M | 6.49%8M |
Financial expense | 11.71%-24.28M | -0.98%-16.05M | -133.92%-9.07M | -942.58%-36.31M | -902.28%-27.49M | -743.25%-15.9M | -335.03%-3.88M | -28.28%-3.48M | ---2.74M | -92.24%-1.88M |
-Interest expense (Financial expense) | -34.53%1.12M | -30.11%835.73K | -20.43%474.88K | 121.49%2.17M | 364.44%1.71M | 1,501.65%1.2M | 597.24%596.77K | 211.63%981.11K | --369.15K | 364.57%74.66K |
-Interest Income (Financial expense) | 12.98%-25.38M | 1.15%-16.87M | -112.37%-9.54M | -773.60%-38.52M | -857.40%-29.17M | -780.13%-17.06M | -356.48%-4.49M | -42.11%-4.41M | ---3.05M | -67.38%-1.94M |
Research and development | 20.05%53.75M | 29.62%36.71M | 34.02%19.08M | 35.27%57.18M | 16.95%44.77M | 43.38%28.32M | 26.95%14.23M | 32.92%42.28M | --38.28M | 12.85%19.75M |
Credit Impairment Loss | -104.42%-11.82M | -1,154.64%-8.24M | -201.82%-4.92M | -142.58%-24.02M | -2,225.50%-5.78M | -238.32%-656.51K | -91.42%-1.63M | -81.12%-9.9M | --272.07K | 87.07%-194.05K |
Asset Impairment Loss | -517.75%-5.02M | -950.94%-1.77M | -327.05%-576.77K | -105.85%-3.44M | 53.78%-813.09K | 81.68%-168.47K | 38.18%-135.06K | -9.14%-1.67M | ---1.76M | 59.16%-919.51K |
Other net revenue | ||||||||||
Invest income | --307.36K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Asset deal income | ---- | ---- | ---- | --102.04K | --84.07K | --84.07K | --84.07K | ---- | ---- | ---- |
Other revenue | 64.80%11.61M | -3.75%6.16M | -13.44%2.8M | -65.93%10.18M | -67.99%7.05M | -59.22%6.4M | -41.26%3.24M | 48.64%29.87M | --22.01M | 207.47%15.68M |
Operating profit | -10.22%29.03M | -60.85%7.2M | -75.12%1.92M | -43.77%65.9M | -12.34%32.33M | -0.43%18.39M | -4.65%7.73M | 7.67%117.2M | 36.88M | 37.10%18.47M |
Add:Non operating Income | 174.94%33.92K | 128.62%25.02K | -35.92%5.58K | -45.99%15.81K | -45.94%12.34K | -7.52%10.94K | 104.52%8.7K | 15.46%29.28K | --22.82K | 197.86%11.83K |
Less:Non operating expense | 1,788.98%6.74M | 8,789.35%6.01M | -99.92%25.75 | 3,606.60%370.66K | 3,468.32%356.83K | --67.58K | --31.94K | 1,086.31%10K | --10K | ---- |
Total profit | -30.22%22.32M | -93.36%1.22M | -74.97%1.93M | -44.08%65.54M | -13.30%31.99M | -0.80%18.34M | -4.99%7.71M | 7.66%117.22M | 36.9M | 37.15%18.49M |
Less:Income tax cost | -195.01%-3.69M | -351.10%-4.67M | -199.26%-2.3M | -80.09%2.24M | -248.07%-1.25M | -592.73%-1.04M | -185.45%-768.87K | -8.10%11.26M | --844.09K | 172.03%210.14K |
Net profit | -21.75%26.01M | -69.60%5.89M | -50.11%4.23M | -40.25%63.3M | -7.81%33.24M | 6.01%19.37M | 17.51%8.48M | 9.66%105.95M | 36.05M | 32.71%18.28M |
Net profit from continuing operation | -21.75%26.01M | -69.60%5.89M | -50.11%4.23M | -40.25%63.3M | -7.81%33.24M | 6.01%19.37M | 17.51%8.48M | 9.66%105.95M | --36.05M | 32.71%18.28M |
Net profit of parent company owners | -21.75%26.01M | -69.60%5.89M | -50.11%4.23M | -40.25%63.3M | -7.81%33.24M | 6.01%19.37M | 17.51%8.48M | 9.66%105.95M | --36.05M | 32.71%18.28M |
Earning per share | ||||||||||
Basic earning per share | -42.86%0.12 | -76.92%0.03 | -57.14%0.03 | -52.75%0.43 | -32.26%0.21 | -18.75%0.13 | 16.67%0.07 | 9.64%0.91 | --0.31 | 33.33%0.16 |
Diluted earning per share | -42.86%0.12 | -76.92%0.03 | -57.14%0.03 | -52.75%0.43 | -32.26%0.21 | -18.75%0.13 | 16.67%0.07 | 9.64%0.91 | --0.31 | 33.33%0.16 |
Other composite income | ||||||||||
Total composite income | -21.75%26.01M | -69.60%5.89M | -50.11%4.23M | -40.25%63.3M | -7.81%33.24M | 6.01%19.37M | 17.51%8.48M | 9.66%105.95M | 36.05M | 32.71%18.28M |
Total composite income of parent company owners | -21.75%26.01M | -69.60%5.89M | -50.11%4.23M | -40.25%63.3M | -7.81%33.24M | 6.01%19.37M | 17.51%8.48M | 9.66%105.95M | --36.05M | 32.71%18.28M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- | -- | -- |
Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.